Diabetes Clinical Trials in Atlanta

Showing 321-340 of 475 trials

Islet Transplantation Using Abatacept

NCT00276250

Islet transplantation in type 1 diabetics with hypoglycemic unawareness using abatacept as a part of a novel calcineurin-inhibitor-sparing immunosuppressive regimen.

Type 1 Diabetes Mellitus

Emory University5 participantsStarted Dec 2005

Atlanta, Georgia, United States

TERMINATEDPhase 3< 1 mile

TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes

NCT01829464

The purpose of this study is to evaluate the effect of TAK-875 (fasiglifam) in combination with sitagliptin on glycemic control in adults with type 2 diabetes.

Diabetes

Takeda90 participantsStarted May 2013

Birmingham, Alabama, United States • Dothan, Alabama, United States • Muscle Shoals, Alabama, United States +83 more locations

Islet Transplantation Using Abatacept

TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes

Diabetes Trials in Other Cities

Open-Label Extension Study to Evaluate Long Term Safety and Treatment Effect of DiaPep277®

BI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).

Glucose Meter Study

Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 Diabetes

Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM

The Health Outcomes Management and Evaluation (HOME) Study

Comparison of TAK-875 to Placebo as an Add-on to Glimepiride in Patients With Type 2 Diabetes

Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 Diabetes

A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes

Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes

A Study of Dipeptidyl-peptidase IV (DPP-IV) RO4876904 in Patients With Type 2 Diabetes.

Southeastern Diabetes Initiative Clinical Intervention

Efficacy and Safety of TAK-379 in Adult Subjects With Type 2 Diabetes Mellitus

T Cell Validation Study Using Blood Samples From Subjects With Recent Onset Type 1 Diabetes Mellitus

Study of How Dulaglutide Compares to Placebo in Participants With Type 2 Diabetes Who Are Also on Sulfonylurea Therapy (AWARD-8)

A Study of RO5093151 and RO5027838 in Patients With Type 2 Diabetes Mellitus on a Stable Dose of Metformin

A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 Diabetes

G5® Mobile Continuous Glucose Monitoring System Automated vs. Manual Sensor Applicator

Other Conditions in Atlanta